Bio

An executive in life sciences with over 25 years of experience in industry, equity research and investment banking. A proven record of driving commercial success and revenue growth. Extensive cross-functional expertise in financial management, operational management, strategic planning, business development, investor relations, cross-border M&A and capital raising in Australia and international markets. Formerly CEO of ASX-listed medicinal cannabis company, AusCann; Chief Business Officer of Arovella Therapeutics; CFO & VP Corporate Development of PYC Therapeutics; and Chief Business Officer of leading UK biotech company, Oxford BioMedica. Prior to industry, a top-rated European equity analyst and investment banker. Qualified accountant and Fellow Member of the Association of Chartered Certified Accountants; BA (Hons) and MA in Chemistry from Oxford University; Graduate of the Australian Institute of Company Directors; and Graduate Certificate in Management (with Distinction) from the Australian Institute of Business.